Delving into the unknown in rhinology and allergy F irst I would like to thank the American Journal of Rhinology and Allergy (AJRA) and Editors-in-Chief Drs. Raj Sindwani and Rakesh Chandra, and Deputy Editor of Allergy Dr. Anju Peters for the opportunity to write the editorial for this month's journal. It is an honor to get to weave the excellent science of the January issue of the AJRA into this editorial. The fields of rhinology and allergy continue to expand into novel treatment areas, and the science behind our understanding of the pathophysiology and outcomes in our field has rapidly advanced. However, the more we think we know, the more unanswered questions that surface. The January issue of the AJRA delves into answering some of these unknown questions.
trolled trials with a total of 990 patients. They concluded that intranasal steroids were superior to oral antihistamines in improving nasal symptoms and quality of life in patients with allergic rhinitis. This study is important for those patients with nasal symptoms of allergic rhinitis who want to minimize the potential polypharmacy effects of some allergy treatment regimens.
In this issue of the AJRA, there are five articles that directly addressed CRS and FESS in several specific groups of patients. Brook et al. 8 evaluated factors that influenced the need for endoscopic sinus surgery in adult patients with cystic fibrosis. The occurrence of functional endoscopic sinus surgery in 115 adult patients with cystic fibrosis was predicted by previous ESS intervention as well as the severity of CFTR mutation. Then D'Anza et al. 9 performed a systematic review of sinonasal imaging in patients with granulomatosis with polyangiitis. The review by D'Anza et al. 9 found seven articles, [10] [11] [12] [13] [14] [15] [16] which comprised 224 patients who met inclusion criteria. They found sinus imaging in granulomatosis with polyangiitis that revealed a spectrum of nonspecific findings; however, the constellation of septal erosion, mucosal thickening, and bony changes should raise suspicion for granulomatosis with polyangiitis.
Shimizu et al. 17 found that nasal polyp fibroblasts played important roles in the pathophysiology of CRS with nasal polyposis by releasing cytokines and extracellular matrix proteins. Scott et al. 18 assessed the oral corticosteroid prescribing habits for rhinosinusitis through the American Rhinologic Society members. They found significant heterogeneity existed in oral corticosteroid prescribing habits for rhinosinusitis, and discrepancies were observed between survey results and evidence-based recommendations. This is an important article given the systemic potential risks of oral corticosteroid usage, and developing standardized oral corticosteroid treatment protocols for rhinosinusitis may improve the quality of care by optimizing clinical outcomes and reducing the risk of complications. Also, Veloso-Teles and Cerejeira 19 studied endoscopic sinus surgery for CRS with nasal polyps. They found that endoscopic surgery proved to be an effective treatment in CRS with nasal polyps but also found a considerable, 31%, rate of recurrence and the need for additional surgery. Studies in this often-recalcitrant CRS group will allow us to build our knowledge base but also allow for future meta-analysis of large groups of patients and their outcomes.
Although not directly related to CRS or functional endoscopic sinus surgery but equally important, Cetiner et al. 20 performed an excellent and well-powered comparison of healing and septal perforation after septoplasty in smokers and non-smokers. Of 281 patients, 88 qualified as smokers and 193 were considered non-smokers. Both nasal recovery time and development of septal perforation proved significantly greater in patients who smoked after septoplasty. This study illustrated the need for continued smoking cessation counseling within the practice of otolaryngology, especially in patients considering nasal surgery.
The last five articles in the January issue of the AJRA do not fit into a single category but all impart significant knowledge within the field 21 in their article entitled "Anosmia: Differential diagnosis, evaluation, and management" reviewed the broad differential diagnosis of the patient with anosmia. This article highlights the need for more and better study of anosmia workup, treatments, and outcomes. Yaniv et al. 22 reported on promising results of a composite removable stent in a sheep model of endoscopic sinus surgery. Wasserzug et al. 23 detailed the involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw. Atighechi et al. 24 described a novel technique for the quantitative examination of nasal tip support. Lastly, in the lone skull base or sinonasal tumor outcomes article, Jiang et al. 25 studied 125 patients with surgery for inverted papilloma. They found no difference in outcomes with a purely endoscopic versus an open approach, nor were there differences in the recurrence risk with stage. The only factor that predicted a worse recurrence risk was previous surgery. Twenty percent of recurrences were detected Ͼ5 years after surgery, which illustrated the need for continued long-term endoscopic follow-up in these patients.
In summary, the January issue of the AJRA answers many questions in the fields of rhinology and allergy, especially in the "gray zone" of our knowledge on the interaction in allergy and CRS, and the optimal treatment regimens for allergy-related sinonasal disease. All the January AJRA authors and their teams should be commended on their excellent work. 
